Grand challenge for ion channels: an underexploited resource for therapeutics.
作者信息
Camerino Diana Conte, Desaphy Jean-François
机构信息
Section of Pharmacology, Department of Pharmacobiology, Faculty of Pharmacy, University of Bari "Aldo Moro" Bari, Italy.
出版信息
Front Pharmacol. 2010 Aug 20;1:113. doi: 10.3389/fphar.2010.00113. eCollection 2010.
Abstract
摘要
相似文献
1
Grand challenge for ion channels: an underexploited resource for therapeutics.离子通道面临的重大挑战：一种未得到充分利用的治疗资源。
Front Pharmacol. 2010 Aug 20;1:113. doi: 10.3389/fphar.2010.00113. eCollection 2010.
2
Therapeutic potential of Voltage gated Calcium channels.电压门控钙通道的治疗潜力
Mini Rev Med Chem. 2008 Oct;8(12):1285-90. doi: 10.2174/138955708786141016.
3
Ion channels as therapeutic targets: a drug discovery perspective.离子通道作为治疗靶点：药物发现视角。
J Med Chem. 2013 Feb 14;56(3):593-624. doi: 10.1021/jm3011433. Epub 2012 Nov 29.
4
A Grand Canonical Monte Carlo-Brownian dynamics algorithm for simulating ion channels.一种用于模拟离子通道的巨正则蒙特卡罗-布朗动力学算法。
Biophys J. 2000 Aug;79(2):788-801. doi: 10.1016/S0006-3495(00)76336-3.
5
Advantages of voltage-gated ion channels as drug targets.电压门控离子通道作为药物靶点的优势。
Expert Opin Ther Targets. 2007 Mar;11(3):265-71. doi: 10.1517/14728222.11.3.265.
6
Ion channel therapeutics for pain.用于疼痛治疗的离子通道疗法。
Channels (Austin). 2015;9(6):344-51. doi: 10.1080/19336950.2015.1075105.
7
Ion channels involved in stroke.
Expert Opin Ther Targets. 2001 Feb;5(1):59-86. doi: 10.1517/14728222.5.1.59.
8
Glycans in Medicinal Chemistry: An Underexploited Resource.药物化学中的聚糖：一种未被充分利用的资源。
ChemMedChem. 2015 Aug;10(8):1291-5. doi: 10.1002/cmdc.201500107. Epub 2015 May 14.
9
Grand challenges in interfacing engineering with life sciences and medicine.工程学与生命科学和医学接口的重大挑战。
IEEE Trans Biomed Eng. 2013 Mar;60(3):589-98. doi: 10.1109/TBME.2013.2244886. Epub 2013 Feb 1.
10
Basics on the use of acid-sensing ion channels' inhibitors as therapeutics.关于使用酸敏感离子通道抑制剂作为治疗药物的基础知识。
Neural Regen Res. 2019 Mar;14(3):395-398. doi: 10.4103/1673-5374.245466.
引用本文的文献
1
Ion Channels in Endometrial Cancer.子宫内膜癌中的离子通道
Cancers (Basel). 2022 Sep 28;14(19):4733. doi: 10.3390/cancers14194733.
2
Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option.先天性肌强直合并慢性炎症性脱髓鞘性多发性神经根神经病患者停用美西律后复发：关于一种潜在治疗选择的病例报告
Medicine (Baltimore). 2020 Jul 10;99(28):e21117. doi: 10.1097/MD.0000000000021117.
3
High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na channel complex.高通量筛选针对蛋白质-蛋白质相互作用界面的研究揭示了抗癌治疗药物作为电压门控钠离子通道复合物的有效调节剂。
Sci Rep. 2019 Nov 15;9(1):16890. doi: 10.1038/s41598-019-53110-8.
4
On the role of water density fluctuations in the inhibition of a proton channel.论水密度波动在质子通道抑制中的作用。
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):E8359-E8368. doi: 10.1073/pnas.1609964114. Epub 2016 Dec 12.
5
A Protein Nanopore-Based Approach for Bacteria Sensing.一种基于蛋白质纳米孔的细菌传感方法。
Nanoscale Res Lett. 2016 Dec;11(1):501. doi: 10.1186/s11671-016-1715-z. Epub 2016 Nov 15.
6
Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.蛋白质-蛋白质相互作用作为离子通道药物发现的新靶点。
Austin J Pharmacol Ther. 2013 Dec 31;1(2).
7
Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex.用于检测电压门控钠通道大分子复合物内蛋白质-蛋白质相互作用的生物发光方法。
Assay Drug Dev Technol. 2012 Apr;10(2):148-60. doi: 10.1089/adt.2011.413. Epub 2012 Feb 24.
本文引用的文献
1
Ion permeation and block of the gating pore in the voltage sensor of NaV1.4 channels with hypokalemic periodic paralysis mutations.低钾型周期性瘫痪突变体钠离子通道电压传感器门控孔的离子渗透和阻断。
J Gen Physiol. 2010 Aug;136(2):225-36. doi: 10.1085/jgp.201010414.
2
Therapeutic approaches to ion channel diseases.离子通道疾病的治疗方法。
Adv Genet. 2008;64:81-145. doi: 10.1016/S0065-2660(08)00804-3.
3
Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms.利用自动化高通量电生理学平台进行钠通道抑制剂药物发现。
Comb Chem High Throughput Screen. 2009 Jan;12(1):107-22. doi: 10.2174/138620709787047993.
4
Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.一类新型电压门控钠通道Nav1.7强效抑制剂的特性研究
Biochemistry. 2007 Dec 18;46(50):14693-703. doi: 10.1021/bi7018207. Epub 2007 Nov 21.
5
Pharmacologic management of neuropathic pain: evidence-based recommendations.神经性疼痛的药物治疗：循证推荐意见
Pain. 2007 Dec 5;132(3):237-251. doi: 10.1016/j.pain.2007.08.033. Epub 2007 Oct 24.
6
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.A-803467是一种强效且具有选择性的Nav1.8钠通道阻滞剂，可减轻大鼠的神经性疼痛和炎性疼痛。
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. doi: 10.1073/pnas.0611364104. Epub 2007 May 2.
7
Ion channel pharmacology.离子通道药理学
Neurotherapeutics. 2007 Apr;4(2):184-98. doi: 10.1016/j.nurt.2007.01.013.
8
Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease.通过分子伴侣进行治疗：正义还是反义？以囊性纤维化为例的模型疾病
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):477-87. doi: 10.1007/s10545-006-0251-x.
9
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.雷诺嗪用于治疗慢性心绞痛及在其他心血管疾病中的潜在用途。
Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500.
10
Calcium-channel modulators for cardiovascular disease.
Expert Opin Emerg Drugs. 2006 Mar;11(1):49-73. doi: 10.1517/14728214.11.1.49.
Zotero 插件